Key result
Endomyocardial biopsy enables giant cell myocarditis diagnosis, guiding immunosuppression to resolve life-threatening arrhythmias.
Why the study?
Giant cell myocarditis is a rare autoimmune myocarditis with high morbidity and mortality that mainly affects middle-aged adults, making its diagnosis in older patients challenging.
Case Report (n=1)
No
This case highlights that a low threshold for endomyocardial biopsy in unexplained acute de novo heart failure with ventricular arrhythmias can yield actionable diagnoses, even in older patients on immunosuppression.
Answers are grounded in this paper and cite their sources.
Supports considering biopsy in unexplained acute HF with arrhythmias even in older adults; leaves open need for prospective validation before practice change.
Giant cell myocarditis is a rare form of autoimmune myocarditis with high morbidity and mortality that affects mainly middle-aged adults. We report a case study of a 70-year-old man on chronic immunosuppression who presented with sustained ventricular tachycardia and symptoms of acute systolic heart failure, both with poor response to standard measures. A decision to pursue endomyocardial biopsy established the diagnosis of GCM and lead to initiation of immunosuppressive therapy and a favourable outcome. Our case illustrates that a low threshold for endomyocardial biopsy in new onset heart failure can lead to actionable information even in patients of advanced age.
No takes yet. Share an insight, caveat, or question.
Dusík et al. (2020) conducted a case report in Giant cell myocarditis (n=1). Endomyocardial biopsy was evaluated. Endomyocardial biopsy successfully established the diagnosis of giant cell myocarditis in a 70-year-old man, leading to targeted immunosuppressive therapy and resolution of life-threatening arrhythmias.
Synapse has enriched 10 related papers. Consider them for comparative context: